A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Advertisement
The Scientist
Most Recent
Advances in genomics and cancer biology will alter the design of human cancer studies.
Contributors
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
Tailoring ethical oversight to participant-led research
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
The method to the dengue virus's maddening infectiousness.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
